Board of Directors

Nationality: British

Committee memberships:  ESG Committee (Chair), Investment Committee, Nomination Committee (Chair), Remuneration Committee 

Appointed: Chair Designate March 2020, Chair July 2020 

Key strengths and experience

• Nearly 40 years’ business management and leadership experience 
• Instrumental in large-scale digital and cultural transformation

As the first female CEO of Lloyd’s of London, from 2014 to 2018, Inga led its expansion  into Dubai, China and India, and advanced diversity and inclusion initiatives across the international insurance sector. Her background in global financial services, insurance and risk management brings a different perspective to the Board’s debates. Previously, she held various senior leadership positions at Converium, Zurich Insurance Group, Canopius and GE Insurance Solutions.

She has been an associate of the Chartered Insurance Institute since 1987 and was appointed Dame Commander of the Order of the British Empire in 2017 for services to the UK economy.

Key external appointments

Independent non-executive director of Crawford & Company, Inc. and Willis Towers Watson plc, member of the supervisory board of NN Group N.V., and Patron of Insuring Women’s Futures.

Nationality: South African

Committee membership: Clinical Performance Committee, ESG Committee, Investment Committee

Appointed: June 2018

Key strengths and experience

• Strong track record of leadership and management within private sector healthcare
• Experience in strategy, organisational development, clinical performance, technology adoption and quality management
• Qualified anaesthesiologist with expertise in intensive care, acute and chronic pain, and trauma, as well as managed healthcare principles and reimbursement models

Ronnie joined Mediclinic in 1999 and served as Chief Clinical Officer before his appointment as Group CEO. He was an executive director of Mediclinic International Ltd from 2010 up to the reverse takeover of Al Noor Hospitals Group plc. Ronnie has extensive knowledge of Mediclinic’s operations. He established the Clinical Services, Clinical Information, Advanced Analytics, Health Information Management and central Procurement functions at Mediclinic, driving growth.

He holds an MBChB (Stellenbosch University), a DA (SA) (College of Anaesthetists of South Africa) and the FCA (SA) (Fellowship of the College of Anaesthetists of South Africa), and has completed the Advanced Management Program (Harvard Business School).

Key external appointments

Non-executive director of Spire since 24 May 2018 under the terms of the shareholder agreement between Spire and Mediclinic.

Nationality: South African

Committee membership: Investment Committee    

Appointed: August 2016

Key strengths and experience

Over 20 years’ broad financial and accounting experience

As a qualified chartered accountant with extensive investment banking experience, Jurgens takes a balanced approach to financial management and growth. Since joining Mediclinic as Group CFO, he has driven a structured approach to capital allocation with an emphasis on free cash flow and ROIC. Previously, he served as CFO at Datatec Ltd. He qualified with KPMG and, in 2001, joined The Standard Bank of South Africa Ltd, where he was appointed as Head of Mergers and Acquisitions in 2009.

He holds a BCom Hons in Accounting (University of Johannesburg) and is registered with the South African Institute of Chartered Accountants.

Key external appointments

None.

Nationality: British

Committee memberships: Clinical Performance Committee (Chair), ESG Committee, Nomination Committee    

Appointed: Independent non-executive director October 2017, Senior Independent Director September 2021

Key strengths and experience

• In-depth knowledge of health sector with both clinical experience and public health expertise 
• Strong insight into healthcare technology and sustainable development

Felicity was previously Director General for Public and International Health for the UK Government; Head of Medicines, Pharmacy and Industry Group at the Department of Health, London; Director of the UK Prime Minister’s Delivery Unit; Director of Prison Health for Her Majesty’s Prison Service; Head of Quality Management at NHS Executive; and Private Secretary to the Chief Medical Officer.

She holds an MBBS (St Bartholomew’s Medical College, University of London), a PgDip in Clinical Microbiology (The Royal London Hospital College, University of London) and an MBA (Henley Management College). She was appointed CBE in 2008 and is an Honorary Fellow of the Royal College of Physicians and a Fellow of the Faculty of Public Health.

Key external appointments

Non-executive director of Guy’s and St Thomas’ NHS Foundation Trust and Halcyon Topco Ltd (ultimate parent company of Sciensus); visiting professor at the Institute of Global Health Innovation, Imperial College London; co-chair of the World Health Organization Independent Oversight and Advisory Committee for Health Emergencies Programme.

Nationality: Emirati

Committee membership: Clinical Performance Committee, Remuneration Committee

Appointed: November 2017

Key strengths and experience

• Significant experience of healthcare and higher education industry in the UAE
• Strategic and tactical expertise in operations, fiscal management and transaction negotiation

Muhadditha contributes valuable insights into the Middle East’s geopolitical landscape. Previously, she was CEO of Dubai Healthcare City; CEO of the Mohammed Bin Rashid Al Maktoum Academic Medical Center; Deputy CEO of Tatweer; a member of Dubai Holding; Executive Dean of the Faculty of Health Sciences, Higher Colleges of Technology (‘HCT’); Acting Deputy Vice Chancellor of Academic Affairs at HCT; and Director of Education of the Harvard Medical School Dubai Center.

She holds a BS in Medical Technology (University of Minnesota), an MSc in Clinical Laboratory Services (University of Minnesota) and a Doctor of Public Health (University of Texas).

Key external appointments

President and chair of the board of trustees of the Sharjah Education Academy; chair of the Sharjah Private Education Authority; a member of the University of Sharjah’s board of trustees, Audit and Compliance Committee and Academic Committee.

Nationality: French, Russian

Committee membership: Audit and Risk Committee, ESG Committee

Appointed: August 2021

Key strengths and experience

• Strong finance background with commercial and strategic focus
• Extensive understanding of data analytics to support transformation

Natalia is a former Chief Commercial Officer of Yum! Brands, Inc. (owner of brands such as KFC) and former CFO of its subsidiary, Taco Bell. A certified professional accountant (RF CPA) and certified management accountant (USA CMA), she was born in Ukraine, and has lived and worked across the United States, Europe, Russia and the UK.

She holds an MEng in Electrical Engineering (Moscow State University of Transport, Russia) and an MBA (Academy of National Economy, Russia), and completed executive education programmes on Valuation, Mergers and Acquisitions (Harvard), Financial Management (Stanford Graduate School of Business), and Organisational Design for Digital Transformation (MIT Sloan School of Management).

Key external appointments

Non-executive director of Domino’s Pizza Group plc, chair of its Sustainability Committee and member of its Audit, Remuneration and Nomination committees; adviser to Kharis Capital, a private equity firm based in Belgium.

Nationality: South African

Committee membership: Audit and Risk Committee, Remuneration Committee

Appointed: February 2022

Key strengths and experience

• Strategic and operational experience in complex, regulated environments
• Strong financial and accounting background
• Diverse experience in listed companies across a breadth of sectors and jurisdictions

Zarina has served as a non-executive director at several companies, including Kumba Iron Ore Limited, Mercedes Benz SA Ltd, Sun International Ltd, Vodacom South Africa Proprietary Ltd, Yebo Yethu Ltd and Woolworths Holdings Ltd, as well as the South African Institute of Chartered Accountants, the Accounting Standards Board, and the Financial Services Board. She also chaired the South African Public Accountants’ and Auditors’ Board, and the South African Auditing Standards Board. Prior to that, she was a partner of Ernst & Young Inc. and, in 2002, joined the Absa Group, where she served as an executive director of Absa Bank, a member of the group’s executive committee and Head of the Private Bank.

She holds a BAcc (University of Durban-Westville) and is registered with the South African Institute of Chartered Accountants.

Key external appointments

Senior independent director of Investec plc and Investec Ltd, the specialist banking and wealth management group with dual listings on the LSE and JSE, and non-executive director of certain of their subsidiaries; non-executive director of JSE Ltd and Oceana Group Ltd, South African companies listed on the JSE.

Nationality: South African

Committee memberships: Investment Committee (Chair), Nomination Committee

Appointed: February 2016*

Key strengths and experience

• Over 20 years’ investment experience with substantial strategic and tactical expertise
• Significant knowledge of capital markets, finance and accounting, risk management, investor relations

Jannie joined the Rembrandt Group in 1996 and became CEO of Remgro in 2012. He is the Board representative for Remgro, which holds a 44.56% interest in the Company. Jannie was a non-executive director of Mediclinic International Ltd from 2012 to 2016, when it combined with the Company (then Al Noor Hospitals Group plc) to become Mediclinic International plc.

He holds a BAcc Hons in Accountancy (Stellenbosch University) and an MPhil in Management Studies (Oxford University). Jannie is registered with the South African Institute of Chartered Accountants.

Key external appointments

CEO of Remgro; non-executive chair for the following listed companies within the Remgro group: Distell Group Holdings Ltd, RCL Foods Ltd and Rand Merchant Investment Holdings Ltd.

* Pieter Uys, the Head of Strategic Investment at Remgro, was appointed as Jannie’s alternate in April 2016. Prior to joining Remgro, he was a founding member and ultimately became the CEO of the Vodacom Group. Pieter holds an MEng in Electronic Engineering (Stellenbosch University) and an Executive MBA (Stellenbosch University).

Nationality: South African

Committee membership: ESG Committee, Investment Committee

Appointed: Non-executive director August 2018, designated non-executive director for workforce engagement April 2019

Strengths and experience

• Significant operational, strategic and risk management experience 
• Extensive knowledge of the healthcare sector

As the former Group CEO, Danie led Mediclinic’s efforts to invest in our workforce and is uniquely positioned to oversee and evaluate employee engagement. He was CEO of Mediclinic from 2010 up to his retirement on 1 June 2018. He became an executive director and Group CEO of the Company on 15 February 2016 upon the Company’s listing on the LSE. Danie served in various management positions in the Remgro group before becoming the Hospital Manager of Mediclinic Sandton in 1985. He joined Mediclinic’s Executive Committee in 1995 and became a director in 1996. He was seconded to the Group’s Dubai operations in 2006 and appointed CEO of Mediclinic Middle East in 2007. He served as a non-executive director of Spire from 2015 to 2018.

He holds a BPL Hons in Industrial Psychology (University of the Free State) and completed the Advanced Management Program (Harvard Business School).

Key external appointments

Non-executive director of Capitec Bank Holdings Ltd and Capitec Bank Ltd.

Nationality: Swiss

Committee memberships: Clinical Performance Committee, Nomination Committee 

Appointed: July 2018

Key strengths and experience

• Experience in healthcare, clients’ needs and the medical operational sector 
• Experience in digital transformation and digital ecosystems in healthcare services
• Insights into political, regulatory and administrative context of healthcare in Switzerland

Anja was previously Deputy Medical Officer in the Department of Health and Head of Medical and Pharmaceutical Services. She served on various cantonal, regional and national committees in Swiss health administration, working closely with political opinion leaders. She was also CEO of a healthcare start-up company and worked several years as a medical doctor in various hospitals.

Anja holds an MD-PhD (University of Basel), specialising in Orthopaedic Surgery and Traumatology, as well as in Sports Medicine; an Executive MBA (University of Rochester-Bern); a certificate in General Management (University of Bern); and a certificate of the Swiss Board School (International Center for Corporate Governance of the University of St. Gallen).

Key external appointments

CEO of Klinik Sonnenhalde AG; member of the boards of Integrierte Psychiatrie Winterthur and Zippsafe AG; Past-President of the Association of Private Hospitals in Basel.

Nationality: British 

Committee memberships: Audit and Risk Committee (Chair), Investment Committee, Remuneration Committee

Appointed: July 2019

Key strengths and experience

• Thorough understanding of UK-listed company environment, including risk management and internal control
• Experience in healthcare, innovation and transformation

Tom’s long career in finance makes him ideally suited to his role as Chair of the Audit and Risk Committee. He is a former non-executive director of Liberty Living Group PLC and DP Eurasia N.V. and previously served as CFO of InterContinental Hotels Group PLC and British United Provident Association (‘BUPA’), a provider of health-related services including private hospitals. Earlier in his career, Tom was CFO and Chief Operating Officer of William Hill PLC and Finance Director of Moss Bros PLC. He started his career in professional services and spent a total of 12 years at Price Waterhouse and McKinsey.

He is a qualified chartered accountant with a BSc Hons Finance and Accounting (University of Bristol) and has completed the Advanced Management Programme (INSEAD).

Key external appointments

Non-executive director of Halfords Group plc, chair of their Audit Committee and member of their ESG, Nomination and Remuneration committees.

Nationality: American

Committee memberships: Audit and Risk Committee, Clinical Performance Committee, Remuneration Committee (Chair)

Appointed: July 2020

Key strengths and experience

• Significant healthcare and international consumer goods experience
• Finance and business transformation leadership roles in large, complex organisations in developed and developing markets

Steve spent the majority of his finance career with the international consumer goods group Unilever, most recently as Group Controller responsible for performance management, accounting, reporting and control. He was a member of Unilever’s Global Finance Leadership Team, working closely with the group’s board and Audit Committee.

He has a Masters in Finance (Columbia University) and a BSc in Management (Rutgers University).

Key external appointments

Non-executive director of Guy’s and St Thomas’ NHS Foundation Trust, chair of their Transformation and Major Programmes Committee and member of their Audit and Risk, Quality and Performance, Remuneration, and Strategy and Partnership committees; non-executive director of King’s College Hospital NHS Foundation Trust and member of its Audit and Finance and Commercial committees.